Alex Mitchell, Vice President, Operations, Sentry BioPharma Services, discusses the growing use of FTZs by pharmaceutical ...
The global Pharmaceutical Quality Management Software Market, valued at US$1.41 billion in 2024, stood at US$1.59 billion in ...
The SCMS market offers opportunities in AI, cloud, and blockchain integration, offering real-time visibility, predictive ...
This session will explore best practices for sourcing and managing comparator products in clinical trials. It is designed to ...
In the life sciences industry, the journey from discovery to delivery is only as strong as the supply chain and distribution ...
The global market for Supply Chain Management Software was valued at US$19.0 Billion in 2024 and is projected to reach US$22.9 Billion by 2030, growing at a CAGR of 3.2% from 2024 to 2030. This ...
Despite a growing maturity of third-party risk management programs, supply chain attacks impacted more organizations in 2025 ...
By Candy P. Dalizon / Contributor The Philippine Universal Health Care (UHC) Law guarantees equitable access to quality health services and essential medicines for all Filipinos. However, complex gaps ...
Law remains clear: equitable access to quality health services and essential medicines for all Filipinos. Yet, gaps in ...
Opinion
Pharmaceutical Technology on MSNOpinion
FDA inspection reveals critical supply chain vulnerabilities
Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into opportunities.
From higher material costs to new tariffs, ASCs could face a new wave of supply chain pressures in 2026. Here are seven key things to know: 1. Medical supply chain costs are projected to rise 2.41% in ...
Medical device makers use AI to turn EU regulatory challenges into competitive advantages via supply chain optimization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback